Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a major worldwide health problem. Recent studies suggest that the gut microbiota influences NAFLD pathogenesis. Here, a murine model of high-fat diet-induced (HFD-induced) NAFLD was used, and the effects of alterations in the gut microbiota on NAFLD were determined. Mice treated with antibiotics or tempol exhibited altered bile acid composition, with a notable increase in conjugated bile acid metabolites that inhibited intestinal farnesoid X receptor (FXR) signaling. Compared with control mice, animals with intestine-specific Fxr disruption had reduced hepatic triglyceride accumulation in response to a HFD. The decrease in hepatic triglyceride accumulation was mainly due to fewer circulating ceramides, which was in part the result of lower expression of ceramide synthesis genes. The reduction of ceramide levels in the ileum and serum in tempol- or antibiotic-treated mice fed a HFD resulted in downregulation of hepatic SREBP1C and decreased de novo lipogenesis. Administration of C16:0 ceramide to antibiotic-treated mice fed a HFD reversed hepatic steatosis. These studies demonstrate that inhibition of an intestinal FXR/ceramide axis mediates gut microbiota-associated NAFLD development, linking the microbiome, nuclear receptor signaling, and NAFLD. This work suggests that inhibition of intestinal FXR is a potential therapeutic target for NAFLD treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hence, treatment with antibiotics ameliorates high-fat-diet-induced NAFLD in mice55.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [55]
In the citing paper
“Conversely, some data also indicate that antagonism of intestinal FXR signaling could improve metabolic parameters in murine models of NAFLD [256,257].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [257]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Human gut microbiota in obesity and after gastric bypass
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819 · cited 1×
“FXR, the central sensor and regulator for the biosynthesis and enterohepatic recycling of bile acids, plays a pivotal role in the control of lipid metabolism (42–45).”
Self-citation
Research works printed but not linked: 1
- 10.1172/jci21025 · DOI · Paper page
Cited by
Items 601–700 of 746
Ferrari, J. T., Guerreiro, G. T. S., Longo, L., da Silveira, T. R., Cerski, C. T. S., Tozawa, E., de Oliveira, C. P. M. S., Álvares‐da‐Silva, M. R., & Cruz, C. U. (2023) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/agl.v53i3.329 · Cited by 2
Recent advances in understanding cross-talk between Bile Acids and Gut Microbiota
Feng, C. C., Zhang, A. H., Miao, J., Sun, H., Han, Y., Gl, Y. G., Wu, F. F., & Wang, X. (2018) · Open Journal of Proteomics and Genomics · doi:10.17352/ojpg.000007 · Cited by 2
Non‐alcoholic Fatty Liver Disease
Rotman, Y., & Kapuria, D. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch52 · Cited by 2
Pathogenetic substantiation of approaches to the treatment of non-alcoholic fatty liver disease.
Bogomolov, P., Мациевич, М. В., Kokina, K. Y., Mayorov, A. Y., & Mishina, E. Е. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-12-1077-1085 · Cited by 2
Levi, M., Takahashi, S., Wang, X. X., & Levi, M. E. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch49 · Cited by 2
Self-citationIdentification and Validation of Hub Immune-Related Genes in Non-Alcoholic Fatty Liver Disease
Li, J., Kou, C., Sun, T., Liu, J., & Zhang, H. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s413545 · Cited by 2
Cardinelli, C. D. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-29102019-110632 · Cited by 2
Gutting out Myc to decrease ceramides
Li, Y., Summers, S. A., & Holland, W. L. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00418-3 · Cited by 2
Bile Acids and Metabolic Syndrome
Taoka, H., & 渡辺, 光. (2017) · Springer eBooks · doi:10.1007/978-4-431-56062-3_15 · Cited by 1
Liu, T. (2016) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 1
Mir, I. H., Hassan, S., Selvin, J., & Thirunavukkarasu, C. (2023) · Springer eBooks · doi:10.1007/978-981-99-5114-7_7 · Cited by 1
Huang, L., Li, H., Yang, W., Huang, L., Chen, Q., Li, S., Zou, Z., Zhao, L., & Zeng, Z. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2504.04017 · Cited by 1
Pan, R., Min, Z., Li, K., Feng, F., Zheng, B., & Luo, X. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70286 · Cited by 1
Chen, Z., Yang, Y., Shi, X., Yang, R., Fang, W., Liang, G., Li, Y., Gao, J., Ma, L., Yang, J., et al. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04774-9 · Cited by 1
Lithocholic Acid Restores Gut Microbiota and Bile Acid Homeostasis to Improve Type 2 Diabetes
Ge, H., Guo, M., Chen, X., Chen, L., Yang, X., Ge, D., Guo, L., Luo, Y., Ge, G., Zhang, L., et al. (2026) · Nutrients · doi:10.3390/nu18020341 · Cited by 1
Self-citationLi, L., Sun, W., Tan, T., Xu, J., Chen, Y., Chen, Y., Gao, G., Ai, X., Zhou, J., Li, Y., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07826-7 · Cited by 1
Su, L., Huo, T., Zhao, X., Pang, Z., Wang, T., Liu, Y., Dou, X., & Jiao, N. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03064 · Cited by 1
Li, M., Zhai, H., Qiao, L., Wang, Z., Yang, L., Zheng, X., Shi, H., Geng, W., & Wang, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1735669 · Cited by 1
Bile acid metabolism: a potential node in the pathogenic network of PCOS
Wu, X., Li, W., Wang, B., & Wang, M. (2026) · Journal of Endocrinology · doi:10.1530/joe-25-0225 · Cited by 1
Probiotic intervention in NAFLD: current progress, challenges, and future potential
Li, H., Wang, W., Hu, X., Chen, H., Chen, L., Lin, S., Yu, C., & Hu, W. (2026) · Food Science and Human Wellness · doi:10.26599/fshw.2026.9251104 · Cited by 1
Yang, H., Zhang, X., Zhou, D., Zou, J., Xu, L., Chen, M., Zhao, S., Dai, J., Wang, X., Du, X., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118225 · Cited by 1
Nawrot, M., Peschard, S., Thibaut, M. M., Ory, K., Vallez, E., Dorchies, E., Touche, V., Dubois‐Chevalier, J., Gheeraert, C., Caron, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-60976-y · Cited by 1
Qu, C., Wang, Y., Ding, J., & Na, L. (2026) · Acta Alimentaria · doi:10.1556/066.2026.00027 · Cited by 1
Yoon, S. J., Eom, J. A., & Suk, K. T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1864805 · Cited by 1
Chen, L., Xiang, H., Hua, X., Liu, Y., Liu, G., Fang, J., & Ding, S. (2026) · Food Reviews International · doi:10.1080/87559129.2026.2715569 · Cited by 1
Dai, X., Wang, Z., Xiao, X., Gao, J., Xing, Y., Gao, Q., Wang, M., He, F., Zhang, Y., Qu, P., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156757 · Cited by 1
Agaro-Oligosaccharides Modulate Gut Microbiota to Improve Lipid Metabolism in Obesity Model Rats
Kuramitsu, K., Kitaura, Y., Karasawa, K., Hoshiba, N., Fujii, T., Takahashi, H., Ohno, E., Funasaka, K., Hirooka, Y., & Tochio, T. (2026) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.72.343 · Cited by 1
Immunomodulatory mechanisms of bile acids in autoimmune diseases along the gut-liver axis
Zhang, S., Xiong, X., Wei, S., Meng, R., An, H., & Chen, L. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104183 · Cited by 1
Liu, Y., Yu, L., Zhang, C., García-Gutiérrez, E., Duan, H., Pan, J., Zhang, C., Zhao, J., Tian, F., Zhai, Q., et al. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-01156-8 · Cited by 1
Intestinal FXR: A New Therapeutic Target for Nonalcoholic Fatty Liver Disease
Bopanna, S., & Shalimar, S. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.08.006 · Cited by 1
Summary of ISN Forefronts Symposium 2015: ‘Immunomodulation of Cardio-Renal Function’
Ruan, X. Z., Guan, Y., Liu, Z.-H., Eckardt, K., & Unwin, R. J. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.06.007 · Cited by 1
Mikrobiota und nichtalkoholische Fettlebererkrankung
Link, A., Thon, C., Sydor, S., & Canbay, A. E. (2019) · Die Gastroenterologie · doi:10.1007/s11377-019-0348-z · Cited by 1
Schneider, K. M., & Trautwein, C. (2020) · Die Gastroenterologie · doi:10.1007/s11377-019-00402-0 · Cited by 1
Antibiotic Therapy as a Risk Factor of Obesity Development in Children
Абатуров, А. Е., & Никулина, А. А. (2020) · Педиатрия Восточная Европа · doi:10.34883/pi.2020.8.2.013 · Cited by 1
Emerging Applications of Metabolomics in Drug Development
Ma, J., Zheng, N., Xie, G.-X., & Li, H.-K. (2018) · Journal of Metabolomics & Systems Biology · doi:10.13188/2329-1583.1000007 · Cited by 1
An emerging probiotic with liver health benefits for smokers
Jia, W. P., & Zheng, X. (2022) · Life Metabolism · doi:10.1093/lifemeta/loac033 · Cited by 1
高, 蕾. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14112870 · Cited by 1
Early modification of the adipose tissue linking obesity and metaflammation
Caputo, T. (2019) · IRIS · Cited by 1
Dong, T. S. (2020) · eScholarship (California Digital Library) · Cited by 1
Homéostasie des céramides et hépatopathies métaboliques
Régnier, M. (2018) · theses.fr (ABES) · doi:10.70675/2fb92711z373cz4b27z8082z7aa3f8930e63 · Cited by 1
Levi, M. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch40
Gut microbial regulation of bile acid metabolism and signaling
Sayin, S. I. (2016) · Gothenburg University Publications Electronic Archive (Gothenburg University)
北畠, 央. (2017) · Institutional Repositories DataBase (IRDB)
The Impact of Gut Microbiota on Liver Injury
Feng, W., & McClain, C. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-58106-4_11
Recent research trends on the pathogenesis of nonalcoholic fatty liver disease.
Takehara, T. (2017) · PubMed · doi:10.11405/nisshoshi.114.807
Blutzuckersenkung durch den Phosphatbinder Sevelamer
KAHL, S. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0328-9
Microbial modulation of metabolic diseases
Molinaro, A. (2018) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Blokker, B. (2018) · UEA Digital Repository (University of East Anglia)
Farr, S. (2017) · TSpace (University of Toronto)
Utilization of Faecal Microbiota in Humans and Animals
kwang-keun, C., Kim, S.-H., Park, S.-Y., Lee, J. M., & Jo, S.-Y. (2020) · Journal of Agriculture & Life Science · doi:10.14397/jals.2020.54.1.1
The Interaction of Nutrition with Nuclear Receptors in Obesity and Diabetes
Tovar‐Palacio, C., Noriega, L. G., Torre-Villalvazo, I., Díaz‐Villaseñor, A., & Palacios‐González, B. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160608-00094
Wren, S. N. (2020) · UA Campus Repository (The University of Arizona)
Stocke, K. S. (2019) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3308
Lim, Y. S. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/139651
Gut Microbiome as Potential Source for Prevention of Metabolic‐Related Diseases
Boonlao, N., Pant, K., & Anal, A. K. (2022) · Wiley eBooks · doi:10.1002/9781119702160.ch17
Chiang, J. Y. L. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727333300.793538896
Aguilar-Salinas, C. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733866855.793558330
Role of sphingolipids in inflammatory carciongensis
El-Hindi, K. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.71949
Chen, W., Luo, L., Xiang, J., Yuane, W., Dan, H., & Wang, K. (2023) · Food Science and Technology · doi:10.5327/fst.04923
Microbiome and Human Health: From Dysbiosis to Therapeutic Interventions
Dhingra, G. G., Kumar, R., Sood, U., Hira, P., Kaur, J., & Lal, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-3126-2_13
The gut microbiome and gut-liver axis in NAFLDPreprint
Guo, C., Ji, J., Wu, J., Wu, L., Feng, J., Li, J., Yu, Q., Dai, W., Li, Y., & Zheng, Y. (2024) · Authorea · doi:10.22541/au.170666810.08665505/v1
Yang, Q., Zhang, L., Li, Q., Gu, M., Qu, Q., Yang, X., Yi, Q., Gu, K., Kuang, L., Hao, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19603636
Self-citationGeng, X., Tian, W., Zhuang, M., Wang, R., Ma, W., Lin, R., Shang, H., Yu, Z., Shen, R., & Li, J. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250283
Rôle de l'hépatokine LECT2 dans l'immunométabolisme du foie
Pophillat, C. (2023) · theses.fr (ABES) · doi:10.70675/d43cb9c7z7b71z4a99z8371z027f4bed3e12
Ying, T., Han, Y., & Liu, M. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.11.048
Research Progress of Non-Alcoholic Fatty Liver Disease from the Perspective of Intestinal Flora
罗, 雪. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153639
Wang, H., Hou, L., Chen, X., Gui, L., Jiang, W., & Tang, W. (2025) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2025.106798
Chen, S., Huang, J., Zhou, C., Dong, S., Wang, Y., Wang, N., Jia, J., Zhou, C., He, X., Li, B., et al. (2025) · ZKG International · doi:10.63386/620773
Pinheiro, M. M., Afonso, M. B., & Rodrigues, C. M. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00003-4
Shevlyukova, T. P., Bulatova, I. A., Vladimirskiy, V. E., Смирнова, E. N., Trofimova, E. S., & Yusupova, A. A. (2025) · Perm Medical Journal · doi:10.17816/pmj42420-40
Diao, P., Zhang, X., Ishiguro, T., Wang, X., Tanabe, K., Hayashi, C., Kittaka, H., Imamura, H., Nakajima, T., Zhang, Z., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149537
Self-citationΑλληλεπιδράσεις γενετικών παραγόντων και μικροβιώματος σε μεταβολικά νοσήματα
Φασούλα, Ν.-Α. (2017) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.4224
Xu, J., Wang, R., You, S., Zhang, L., Zheng, P., Ji, G., & Liu, B. (2020) · Figshare · doi:10.6084/m9.figshare.12462644
Self-citationYang, Q., Zhang, L., Li, Q., Gu, M., Qu, Q., Yang, X., Yi, Q., Gu, K., Kuang, L., Hao, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19603627
Self-citationBarretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456699
Barretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456690
Deciphering the role of the gut microbiota in murine MASH and MASH-to-HCC transition
Schühle, S. (2024) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00034638
Yang, Q., Zhang, L., Li, Q., Gu, M., Qu, Q., Yang, X., Yi, Q., Gu, K., Kuang, L., Hao, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19603630
Self-citationBarretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456696
Barretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456693
Barretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456714
Barretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456705
Yang, Q., Zhang, L., Li, Q., Gu, M., Qu, Q., Yang, X., Yi, Q., Gu, K., Kuang, L., Hao, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19603633
Self-citationBarretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456681
Xu, J., Wang, R., You, S., Zhang, L., Zheng, P., Ji, G., & Liu, B. (2020) · Figshare · doi:10.6084/m9.figshare.12462650
Self-citationBarretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456687
Barretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456684
Xu, H., Fang, F., Wu, K., Song, J., Li, Y., Lu, X., Liu, J., Zhou, L., Yu, W., Yu, F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24633286
Ahmed, H. (2019) · UEF eRepo (University of Eastern Finland)
Deciphering the relationship among nutrition, host and microbe
Chac, D. (2019) · ResearchWorks at the University of Washington (University of Washington)
YAP1 Signaling in Hepatobiliary Development and Oncogenesis
Molina, L. M. (2021) · D-Scholarship@Pitt (University of Pittsburgh)
Giannitrapani, L., Ferraro, M., Seidita, A., Licata, A., & Soresi, M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i12.110076
A Review on Farnesoid X Receptor (FXR) Modulators Focusing on Benzimidazole Scaffold
Teno, N., Gohda, K., & Fujimori, K. (2026) · Molecules · doi:10.3390/molecules31030450
Yu, S.-R., Sun, R., Shi, M.-Y., Yang, M., Chen, K., Pan, Q., Zhao, L., Wu, M.-Y., & Chai, J. (2026) · Liver Research · doi:10.1016/j.livres.2026.02.001 · Cited by 1
Detergents without a drain: the evolutionary logic (and liability) of sphingolipids
Summers, S. A. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.100998
Profiling the microbiota to develop innovative therapies for infectious diarrhea
Chen, C. (2025) · IRIS
Song, L., Zhou, Y., Zhan, Z., Pan, L., & Fang, L. (2026) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2026.100790
Vairappan, B., Chandrasekar, A., & Ravikumar, T. S. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156439
Metadata
- Authors
- Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., Tanaka, N., Desai, D., Amin, S. G., Albert, I., Patterson, A. D., & Gonzalez, F. J.
- Affiliations
- National Institutes of Health (US)
- Pennsylvania State University (US)
- Corresponding author
- Patterson, Andrew D.
- Gonzalez, Frank J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-12-15
- Volume
- 125
- Issue
- 1
- Pages
- 386-402
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4382255
- OpenAlex
- W2124025733
- Cited by
- 693
- References
- 68
- Citations by year
- 2026: 43 · 2025: 52 · 2024: 52 · 2023: 61 · 2022: 76 · 2021: 84 · 2020: 70 · 2019: 63 · 2018: 58 · 2017: 61 · 2016: 46 · 2015: 26
- FWCI
- 33.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences (R01ES022186, ES022186)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- non-alcoholic fatty liver disease, gut microbiota, bile acids, bile acid conjugates, ceramide, ceramide synthesis, SREBP-1c, de novo lipogenesis, hepatic steatosis, high-fat diet, antibiotic therapy, tempol, nuclear receptor signaling, therapeutic target
- MeSH terms
- Receptor, Farnesoid X-Activated, Animals, Anti-Bacterial Agents, Bile Acids and Salts, Cecum, Gene Expression Regulation, Humans, Ileum, Liver, Male, Mice, Inbred C57BL, Mice, Transgenic, Gene Expression, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Metabolic Networks and Pathways, Diet, High-Fat, Mitochondrial Dynamics, Microbiota, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.